Navigation Links
AVAC Says Results of New PrEP Trials Provide Clear Evidence that Antiretroviral Drugs for Prevention Can Help End the AIDS Epidemic; Calls for Quick Action to Move Landmark HIV Prevention Results Toward Lifesaving Programs
Date:7/13/2011

NEW YORK, July 13, 2011 /PRNewswire-USNewswire/ -- Results from two African studies of pre-exposure prophylaxis, or PrEP, released today provide clear evidence that the antiretroviral drugs used to treat HIV can also be used to prevent HIV among heterosexual men and women at risk of HIV infection.

"These results are tremendously exciting and confirm that we are at pivotal period in the AIDS epidemic," said Mitchell Warren, AVAC executive director. "Antiretroviral (ARV) drugs for HIV treatment began to turn the tide of the epidemic 15 years ago, and it is clear that also using ARVs for HIV prevention will strengthen our response to AIDS. PrEP, ARV-based microbicides and treatment as prevention are powerful tools to help end the cycle of new infections and end the epidemic."

"We now have data that earlier treatment initiation in HIV-positive people can reduce risk of HIV transmission—and that use of ARVs in HIV-negative people can reduce risk of infection. There is a global imperative to act on these results without delay," Warred added. "Now is the time to include ARV-based prevention in national plans, applications to the Global Fund to Fight AIDS, Tuberculosis and Malaria and donor priorities. We need ambitious pilot and demonstration projects to guide programmatic design, along with national and international guidance on how best to use ARVs as lifesaving prevention tools. The next steps will not be simple but they will be essential. Scientific data do not change the world—programs and policies backed by civil society, donors, implementers and governments do. The countries where PrEP trials took place should lead the way in these critical efforts."

"We congratulate the trial sponsors, scientific collaborators and partners who conducted these trials. We especially want to thank the more than 10,000 men and women whose altruism and commitment as trial volunteers made this effort possible," Warren said. "These volunteers and thei
'/>"/>

SOURCE AVAC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Jazz Pharmaceuticals Announces Second Quarter 2011 Results Conference Call on July 28
2. Sanofi and Regeneron Report Positive Phase 2b Trial Results with Sarilumab in Rheumatoid Arthritis
3. Cynosure to Host Second-Quarter 2011 Financial Results Conference Call on July 26
4. Endologix to Report Second Quarter 2011 Financial Results on July 21, 2011
5. Imagenetix, Inc. Discusses March 31, 2011 Fiscal Year End Results and Future Focus
6. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
7. Generex Provides Preliminary Results of Generex Oral-lyn™ Clinical Trials in Patients with Type 1 Diabetes and Patients with Impaired Glucose Tolerance
8. ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2011 Results
9. Cepheid Schedules 2011 Second Quarter Financial Results Announcement and Webcast
10. Par Pharmaceutical Companies to Report Second Quarter 2011 Results on August 3, 2011
11. Diplomat Specialty Pharmacy 2011 Patient Satisfaction Survey Results Affirm Success of Companys Patient Focused Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... -- HeartWare International, Inc . (NASDAQ: ... circulatory support technologies that are revolutionizing the treatment of ... for the second quarter ended June 30, 2014, a ... the same period of 2013. During the ... were sold globally compared to 523 units in the ...
(Date:7/31/2014)... 2014 Second Quarter Total Revenue $2.0 billion; an increase of ... 4% for same store sales and 8% pro forma, excluding ... , 2014 Second Quarter GAAP EPS $0.37; Cash EPS $1.91, ... Operating Cash Flow $376 million; Adjusted Operating Cash Flow $500 ... Launched 17 new products in the U.S. year-to-date , ...
(Date:7/31/2014)... , 31 juli 2014 De Pfizer ... een rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf voor ... gevestigde PCRU is één van twee onderzoekseenheden ... als ideaal levens te verbeteren door de ontdekking en ... de PCRU op zoek naar mannen en vrouwen van ...
Breaking Medicine Technology:HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 2HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 3HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 4HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 5HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 6HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 7HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 8HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 9HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 10HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 11HeartWare International Reports $70.1 Million In Second Quarter 2014 Revenue; 38% Increase From Second Quarter 2013 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25
... PARSIPPANY, N.J., Sept. 15, 2011 Fidia Farmaceutici S.p.A. ... ® (sodium hyaluronate), an injectable treatment for knee ... and physical therapy are not enough, will be transferred ... 24, 2011.  Fidia Farmaceutici S.p.A. is the owner and ...
... September 15, 2011 Oramed Pharmaceuticals Inc. ... oral delivery systems, announced today that Ehud Arbit, M.D., ... present at the 8th Annual Israel Strategic Partner and ... Bristol-Myers Squibb Pharmaceutical Research Institute in Princeton, NJ on ...
Cached Medicine Technology:HYALGAN® (sodium hyaluronate) Commercial Rights Transfer Back to Fidia Farmaceutici S.p.A. 2Oramed Pharmaceuticals Chosen to Present at the 8th Annual Israel Strategic Partner and Venture Conference on September 22, 2011 2
(Date:7/31/2014)... Thousands of independent community pharmacists, ... have come together today to kick off ThoughtSpot ... , "ThoughtSpot 2014 is Good Neighbor Pharmacy’s annual ... to help their businesses thrive," stated AJ Caffentzis, ... long-standing commitment to independent community pharmacies, and at ...
(Date:7/31/2014)... 31, 2014 Web Programming Services, a ... certified internet marketing firm, has recently launched a new ... this service affordable for everyone, the company has announced ... , Web Programming Services has tailored the service ... brochure designing and likely expectations of the clients from ...
(Date:7/31/2014)... Agebc.com, a popular online shop of wedding dresses and women’s ... mother of the bride dresses . Aside from that, ... to 68% off. , “We are proud to enrich ... of the bride dresses. We launch the special offer to ... shop has received thousands of rave reviews from new and ...
(Date:7/31/2014)... new study by researchers at Sanford-Burnham Medical Research Institute ... convert existing cells in the pancreas into those cells ... published online July 31 in Cell Death and ... estimated 3 million people in the U.S., and over ... "We have found a promising technique for type 1 ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Quincy Bioscience, ... of brain health supplement Prevagen®, releases the second edition ... Marvelous Tips for Making Memories: Birth of a Grandchild. ... that offers exceptional memory-making tips and ideas for grandparents ... birth of a grandchild. Each concept published in the ...
Breaking Medicine News(10 mins):Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 2Health News:Good Neighbor Pharmacy’s ThoughtSpot Begins Today with Record Attendance 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Mother of the Bride Dresses Now Available With Great Discounts at Agebc.com 2Health News:A new way to generate insulin-producing cells in Type 1 diabetes 2Health News:Quincy Bioscience Launches the Second E-Book of the Making Memories Series 2
... Surprising finding shows it reduces risk of death, recurrence , ... soy foods can help lower the risk of death and ... shows. , What,s more, the association between soy and a ... estrogen receptor-positive cancers and women taking tamoxifen, according to the ...
... ... that a new market research report is available ... for Interventional Cardiology 2009 (15 Countries) ... European market for interventional cardiology was valued at ...
... , ... new market research report is available in its catalogue: ... Players, and Important Trends) , http://www.reportlinker.com/p0167109/EMR-2010-Market-Analysis-ARRA-Incentives-Key-Players-and-Important-Trends.html ... Kalorama Information surveyed the market for electronic medical records. ...
... your cool with misbehaving children is a challenge. We all ... out at someone without thinking. A new study by ... parents with poorer working memory skills are less likely to ... "Angry, oppositional behavior in children is aversive and challenging to ...
... , Woodbury, N.Y., Dec. 8 On December 9 ... and Miami schools to perform the live nutrition rock concert, ... Dietitian and musician is appearing free to schools courtesy of ... programs. This interactive show promotes healthy eating by ...
... Dec. 8 Tipping Point Community, a charitable organization dedicated ... million donation from the Sergey Brin and Anne Wojcicki Foundation. ... Annual Awards Breakfast and is one of Tipping Point,s largest ... one-quarter of families are too poor to meet their basic ...
Cached Medicine News:Health News:Soy Beneficial for Breast Cancer Survivors: Study 2Health News:Soy Beneficial for Breast Cancer Survivors: Study 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 2Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 3Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 4Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 5Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 6Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 7Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 8Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 9Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 10Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 11Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 12Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 13Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 14Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 15Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 16Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 17Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 18Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 19Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 20Health News:Reportlinker Adds European Markets for Interventional Cardiology 2009 (15 Countries) 21Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 2Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 3Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 4Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 5Health News:Reportlinker Adds EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends) 6Health News:Breakfast BREAKS(R) 'Jump with Jill' Rockin' Nutrition Show Kicks off Tour in Florida Schools 2Health News:Tipping Point Community Announces $1 Million Gift at Third Annual Awards Breakfast 2
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. Depth: 500 to 600....
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. Depth: 500 to 700....
Designed to remove cell debris or tissue remnants from the retina....
... Medtronic presents the Streamline family of ... have taken the gold standard in temporary ... that make them easy to use and ... Streamline Temporary Pacing Leads are designed to ...
Medicine Products: